Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1969 Jun;48(6):1150–1158. doi: 10.1172/JCI106072

Determination of triiodothyronine concentration in human serum

Kenneth Sterling 1,2, Diego Bellabarba 1,2, Edward S Newman 1,2, Milton A Brenner 1,2
PMCID: PMC322330  PMID: 5771194

Abstract

A simplified method has been described for the measurement of triiodothyronine (T3) in human serum. The sensitivity was sufficient for determinations on hypothyroid as well as normal and thyrotoxic sera. The values obtained have been in reasonable agreement with a double isotope derivative assay.

The normal T3 concentration in human serum approximates 0.2 μg/100 ml; the mean ±SD of 31 normal sera was 220 ±27 ng/100 ml. Elevations were observed in sera from 40 patients with thyrotoxicosis (752 ±282 ng/100 ml), and diminutions were found in sera from 10 hypothyroid patients (98±48 ng/100 ml).

In rare instances thyrotoxicosis may be due to elevated serum T3 with normal thyroxine (T4) concentration. The incidence of this condition remains to be determined.

In approximately half the cases with low serum T4 after 131I therapy, the eumetabolic state may be maintained by normal or elevated T3 concentration.

From these data and kinetic studies indicating a rapid turnover it may be inferred that T3 rather than T4 may be the more important hormone in health and in disease.

Full text

PDF
1150

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARONS W. L., HYDOVITZ J. D. The serum pattern of thyroid hormones in euthyroidism and hyperthyroidism. J Clin Endocrinol Metab. 1959 May;19(5):548–556. doi: 10.1210/jcem-19-5-548. [DOI] [PubMed] [Google Scholar]
  2. AROSENIUS K. E., PARROW A. THE SEPARATION OF IODO-AMINO ACIDS FROM THYROID DIGESTS AND BLOOD SERUM, USING ANION-EXCHANGE RESINS AND HIGH-VOLTAGE PAPER ELECTROPHORESIS. Scand J Clin Lab Invest. 1964;16:447–456. doi: 10.3109/00365516409060538. [DOI] [PubMed] [Google Scholar]
  3. AROSENIUS K. E. STUDIES ON THE IODO-AMINO ACIDS IN BLOOD SERUM. Acta Soc Med Ups. 1963;68:215–224. [PubMed] [Google Scholar]
  4. BENUA R. S., DOBYNS B. M. Iodinated compounds in the serum, disappearance of radioactive iodine from the thyroid, and clinical response in patients treated with radioactive iodine. J Clin Endocrinol Metab. 1955 Jan;15(1):118–130. doi: 10.1210/jcem-15-1-118. [DOI] [PubMed] [Google Scholar]
  5. BENUA R. S., DOBYNS B. M., NINMER A. Triiodothyronine in the serum of patients treated with radioactive iodine. J Clin Endocrinol Metab. 1955 Nov;15(11):1367–1378. doi: 10.1210/jcem-15-11-1367. [DOI] [PubMed] [Google Scholar]
  6. Bellabarba D., Peterson R. E., Sterling K. An improved method for chromatography of iodothyronines. J Clin Endocrinol Metab. 1968 Feb;28(2):305–307. doi: 10.1210/jcem-28-2-305. [DOI] [PubMed] [Google Scholar]
  7. DINGLEDINE W. S., PITTRIVERS R., STANBURY J. B. Nature and transport of the iodinated substances of the blood of normal subjects and of patients with thyroid disease. J Clin Endocrinol Metab. 1955 Jun;15(6):724–731. doi: 10.1210/jcem-15-6-724. [DOI] [PubMed] [Google Scholar]
  8. EKINS R. P. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta. 1960 Jul;5:453–459. doi: 10.1016/0009-8981(60)90051-6. [DOI] [PubMed] [Google Scholar]
  9. FEUER G. The formation of thyroid hormones in vivo after the administration of I-131 labelled potassium iodide and thyrotropic hormone. Biochem J. 1959 Oct;73:349–355. doi: 10.1042/bj0730349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GREEN W. L., INGBAR S. H. The peripheral metabolism of tri- and tetraiodothyroacetic acids in man. J Clin Endocrinol Metab. 1961 Dec;21:1548–1565. doi: 10.1210/jcem-21-12-1548. [DOI] [PubMed] [Google Scholar]
  11. GROSS J., PITT-RIVERS R., TROTTER W. R. Effect of 3:5:3'-L-triiodothyronine in myxoedema. Lancet. 1952 May 24;1(6717):1044–1045. doi: 10.1016/s0140-6736(52)90695-8. [DOI] [PubMed] [Google Scholar]
  12. GROSS J., PITT-RIVERS R. The identification of 3:5:3'-L-triiodothyronine in human plasma. Lancet. 1952 Mar 1;1(6705):439–441. doi: 10.1016/s0140-6736(52)91952-1. [DOI] [PubMed] [Google Scholar]
  13. Greer M. A., Grimm Y., Studer H. Qualitative changes in the secretion of thyroid hormones induced by iodine deficiency. Endocrinology. 1968 Dec;83(6):1193–1198. doi: 10.1210/endo-83-6-1193. [DOI] [PubMed] [Google Scholar]
  14. Heninger R. W., Albright E. C. Effect of iodine deficiency on iodine-containing compounds of rat tissues. Endocrinology. 1966 Aug;79(2):309–315. doi: 10.1210/endo-79-2-309. [DOI] [PubMed] [Google Scholar]
  15. Hollander C. S. On the nature of the circulating thyroid hormone: clinical studies of triiodothyronine and thyroxine in serum using gas chromatographic methods. Trans Assoc Am Physicians. 1968;81:76–91. [PubMed] [Google Scholar]
  16. INGBAR S. H. Observations concerning the binding of thyroid hormones by human serum prealbumin. J Clin Invest. 1963 Feb;42:143–160. doi: 10.1172/JCI104701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. INGBAR S. H. Pre-albumin: a thyroxinebinding protein of human plasma. Endocrinology. 1958 Aug;63(2):256–259. doi: 10.1210/endo-63-2-256. [DOI] [PubMed] [Google Scholar]
  18. INGBAR S. H. The interaction of the thyroid hormones with the proteins of human plasma. Ann N Y Acad Sci. 1960 Apr 23;86:440–453. doi: 10.1111/j.1749-6632.1960.tb42821.x. [DOI] [PubMed] [Google Scholar]
  19. LERMAN J. The physiologic activity of l-triiodothyronine. J Clin Endocrinol Metab. 1953 Nov;13(11):1341–1346. doi: 10.1210/jcem-13-11-1341. [DOI] [PubMed] [Google Scholar]
  20. MACK R. E., HART K. T., DRUET D., BAUER M. A. An abnormality of thyroid hormone secretion. Am J Med. 1961 Feb;30:323–326. doi: 10.1016/0002-9343(61)90103-6. [DOI] [PubMed] [Google Scholar]
  21. MACLAGAN N. F., BOWDEN C. H., WILKINSON J. H. The metabolism of thyroid hormones. 2. Detection of thyroxine and tri-iodothyronine in human plasma. Biochem J. 1957 Sep;67(1):5–11. doi: 10.1042/bj0670005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MURPHY B. E., PATTEE C. J. DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. J Clin Endocrinol Metab. 1964 Feb;24:187–196. doi: 10.1210/jcem-24-2-187. [DOI] [PubMed] [Google Scholar]
  23. Murphy B. E. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab. 1967 Jul;27(7):973–990. doi: 10.1210/jcem-27-7-973. [DOI] [PubMed] [Google Scholar]
  24. Nauman J. A., Nauman A., Werner S. C. Total and free triiodothyronine in human serum. J Clin Invest. 1967 Aug;46(8):1346–1355. doi: 10.1172/JCI105627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. PIND K. Paperchromatographic determination of thyroid hormone (3,5,3'-triiodothyronine) in serum without radio-iodine. Acta Endocrinol (Copenh) 1957 Nov;26(3):263–272. doi: 10.1530/acta.0.0260263. [DOI] [PubMed] [Google Scholar]
  26. RUPP J. J., CHAVARRIA C., PASCHKIS K. E., CHUBLARIAN E. The occurrence of tri-iodothyronine as the only circulating thyroid hormone. Ann Intern Med. 1959 Aug;51:359–362. doi: 10.7326/0003-4819-51-2-359. [DOI] [PubMed] [Google Scholar]
  27. RUPP J. J., PASCHKIS K. E. The changing pattern of circulating iodinated amino acids in a case of thyrotoxicosis. Am J Med. 1961 Mar;30:472–474. doi: 10.1016/0002-9343(61)90055-9. [DOI] [PubMed] [Google Scholar]
  28. SHIMAOKA K., JASANI B. M. THE APPLICATION OF TWO-DIMENSIONAL PAPER CHROMATOGRAPHY AND LOW-LEVEL COUNTING TO THE STUDY OF TRIIODOTHYRONINE IN PLASMA. J Endocrinol. 1965 Apr;32:59–64. doi: 10.1677/joe.0.0320059. [DOI] [PubMed] [Google Scholar]
  29. SHIMAOKA K. Toxic adenoma of the thyroid, with triiodothyronine as the principal circulating thyroid hormone. Acta Endocrinol (Copenh) 1963 Jun;43:285–293. doi: 10.1530/acta.0.0430285. [DOI] [PubMed] [Google Scholar]
  30. STERLING K., CHODOS R. B. Radiothyroxine turnover studies in myxedema, thyrotoxicosis, and hypermetabolism without endocrine disease. J Clin Invest. 1956 Jul;35(7):806–813. doi: 10.1172/JCI103333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. STERLING K., LASHOF J. C., MAN E. B. Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects. J Clin Invest. 1954 Jul;33(7):1031–1035. doi: 10.1172/JCI102970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. STERLING K. THYROXINE IN BLOOD. Mayo Clin Proc. 1964 Aug;39:586–608. [PubMed] [Google Scholar]
  33. WERNER S. C., ROW V. V., RADICHEVICH I. Nontoxic nodular goiter with formation and release of a compound with the chromatographic mobility characteristics of triiodothyronine. J Clin Endocrinol Metab. 1960 Oct;20:1373–1383. doi: 10.1210/jcem-20-10-1373. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES